Accumulating evidences indicated that eIF3f expression is elevated in certain types of cancers, but decreased in other types of cancer.[10] These findings suggest that the role of eIF3f involved in different cancers remained ambivalent and the mechanism associated with this deregulation is not fully understood. This evidence concerns the gene EIF3F and cancer.